Bioterrorism Threat Shines Spotlight on Drug Manufacturing

December 2, 2001

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-12-02-2001, Volume 25, Issue 12

Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.

Related Content: